Billionaire New York–Palm Beach Trump Ally Paul Singer Poised For Citgo Fortune After Maduro’s Ouster (Hoodline.com) ...
Despite a year of trade tensions, national security strictures and stark warnings about the U.S.’ waning biotech innovation edge, the fact remains that China is and will likely continue to be a ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage biotechs in the bunch. The analysts’ selections for the upcoming year span ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Boston biotech is coming off ...
Something remarkable is happening in Chinese biotech, and it’s happening fast. The country’s drug developers are learning to run — really run — through clinical trials and regulatory approvals. In an ...
HIGHLAND PARK Fla. — A Florida nonprofit is on a mission to revive the state’s farmland with sustainability in mind. Biotech Applied Research is turning waste into “biochar,” a charcoal-like material.
16:38 EST Femasys (FEMY) files to sell 68.42M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback